IVERIC bio Stock Soars After Encouraging Geographic Atrophy Trial Data
September 06, 2022 at 07:51 AM EDT
IVERIC bio Inc(NASDAQ: ISEE)announced positive datafrom the second Phase 3 trial of Zimura (avacincaptad pegol) for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.